Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-Diabetes

NCT00118963 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Metformin
DRUG: Insulin BIAsp30 (Novolog 70/30)
DRUG: Repaglinide
DRUG: Placebo-Metformin
DRUG: Placebo-Repaglinide

Sponsor

Steno Diabetes Center Copenhagen